Intra-Cellular Therapies Inc. buy JPMorgan Chase & Co.
Start price
09.03.23
/
50%
€41.80
Target price
09.03.24
€54.81
Performance (%)
45.22%
End price
10.03.24
€60.70
Summary
This prediction ended on 10.03.24 with a price of €60.70. With a performance of 45.22% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | -8.271% | -8.271% | 2.694% |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten